Miller Howard Investments Inc. NY Has $20.38 Million Stake in Nutrien Ltd. (NYSE:NTR)

Miller Howard Investments Inc. NY trimmed its position in shares of Nutrien Ltd. (NYSE:NTRFree Report) by 11.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 455,429 shares of the company’s stock after selling 61,660 shares during the period. Miller Howard Investments Inc. NY’s holdings in Nutrien were worth $20,380,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of NTR. AQR Capital Management LLC raised its position in Nutrien by 28.4% in the second quarter. AQR Capital Management LLC now owns 5,348 shares of the company’s stock worth $272,000 after purchasing an additional 1,184 shares in the last quarter. CWM LLC lifted its position in shares of Nutrien by 30.6% during the 3rd quarter. CWM LLC now owns 7,738 shares of the company’s stock worth $372,000 after buying an additional 1,815 shares during the period. Cardinal Capital Management Inc. grew its position in Nutrien by 4.3% in the third quarter. Cardinal Capital Management Inc. now owns 564,078 shares of the company’s stock valued at $27,139,000 after acquiring an additional 23,117 shares during the period. Viking Fund Management LLC acquired a new position in Nutrien during the third quarter worth $96,000. Finally, MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH lifted its holdings in shares of Nutrien by 58.1% during the third quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 2,598 shares of the company’s stock valued at $125,000 after acquiring an additional 955 shares during the period. 63.10% of the stock is currently owned by institutional investors.

Nutrien Stock Down 0.4 %

Shares of NTR stock opened at $50.32 on Friday. Nutrien Ltd. has a 52-week low of $43.69 and a 52-week high of $60.87. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.82 and a current ratio of 1.27. The stock has a market cap of $24.71 billion, a price-to-earnings ratio of 33.77, a PEG ratio of 1.13 and a beta of 0.81. The firm’s 50-day moving average is $48.73 and its 200-day moving average is $48.11.

Nutrien (NYSE:NTRGet Free Report) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.04). Nutrien had a net margin of 2.79% and a return on equity of 6.99%. The business had revenue of $5.35 billion during the quarter, compared to analyst estimates of $5.26 billion. During the same period in the previous year, the business earned $0.35 earnings per share. The business’s quarterly revenue was down 5.0% on a year-over-year basis. Sell-side analysts predict that Nutrien Ltd. will post 3.49 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on NTR. Raymond James upgraded Nutrien from a “market perform” rating to an “outperform” rating and increased their price target for the stock from $58.00 to $60.00 in a research report on Tuesday, December 3rd. TD Securities reduced their price target on shares of Nutrien from $63.00 to $61.00 and set a “buy” rating on the stock in a research report on Tuesday, November 12th. CIBC reaffirmed an “outperformer” rating and issued a $55.00 target price (down from $60.00) on shares of Nutrien in a research note on Tuesday, December 10th. Oppenheimer assumed coverage on shares of Nutrien in a research report on Thursday, December 12th. They set an “outperform” rating and a $60.00 target price on the stock. Finally, Wells Fargo & Company boosted their price objective on shares of Nutrien from $52.00 to $53.00 and gave the stock an “equal weight” rating in a research report on Tuesday, January 28th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $58.94.

View Our Latest Report on NTR

Nutrien Company Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Featured Stories

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.